Home > Insider Trading > Filing (0001021771-23-000088)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1505497	Biorestorative Therapies Inc.	BRTX	Services-Misc Health & Allied Services, Nec (8090)	911835664

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1756228	Lance Alstodt	Biorestorative Therapies, Inc. 40 Marcus Drive, Suite 1 Melville NY 11747	President, Ceo, Cob	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-09-06	2,887	$1.96	187,305	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$5.08	2031-03-18	293,479	293,479	Direct
Common Stock	Stock Option	$5.08	2031-11-04	42,059	42,059	Direct
Common Stock	Stock Option	$2.91	2033-02-17	106,762	106,762	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2031-03-18	293,479	293,479	Direct
2031-11-04	42,059	42,059	Direct
2033-02-17	106,762	106,762	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $1.93 to $2.02 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Includes 48,912 shares received pursuant to an unvested restricted stock unit grant. Such shares vest on March 18, 2024.
The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 and 21,029 shares in eight nearly equal quarterly installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
The option vests and becomes exercisable to the extent of 53,381 shares on February 17, 2023 and 53,381 shares in eight nearly equal quarterly installments beginning February 17, 2024 and continuing every three months thereafter until fully vested.